The global pharmaceutical industry relies on a complex network of suppliers for critical raw materials and intermediates. L-N-Butylsulfonyl-P-Hydroxyphenylalanine, CAS 149490-60-8, stands out as a vital intermediate, particularly in the synthesis of antithrombotic drugs like Tirofiban. For research scientists and procurement managers worldwide, understanding how to effectively source this compound is crucial for advancing drug development and ensuring consistent production.

China has become a dominant force in the global supply of pharmaceutical intermediates, offering a vast array of chemical manufacturers. When seeking to purchase L-N-Butylsulfonyl-P-Hydroxyphenylalanine, manufacturers often turn to these Chinese suppliers due to competitive pricing and accessibility. Key considerations during the sourcing process include verifying the supplier's reliability, the purity of the chemical (typically specified at 98% or higher), and the stability of their production capacity. Engaging with a manufacturer that provides a detailed Certificate of Analysis (CoA) is standard practice.

The 'price' of CAS 149490-60-8 is influenced by market demand, purity levels, and order volume. Companies looking to buy this intermediate in bulk can often negotiate more favorable terms, making it an economically viable choice for large-scale pharmaceutical manufacturing. Establishing a direct relationship with a supplier allows for better communication, potential custom synthesis options, and a more secure supply chain.

For any pharmaceutical company looking to procure this essential component, partnering with a reputable manufacturer in China offers significant advantages. It ensures access to high-quality materials at competitive prices, supporting the ongoing development and production of critical medicines that improve patient health globally. These suppliers are integral to the pharmaceutical industry's ability to meet demands efficiently.